1
|
Malek NM, Grosset DG. Enhancing dopamine treatments: worth the effort? Neurodegener Dis Manag 2012. [DOI: 10.2217/nmt.12.36] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
SUMMARY Dopamine-based treatments underlie our current management of the motor symptoms of Parkinson’s disease. In this article, we look at the development of levodopa therapy, combination therapies with levodopa/dopa decarboxylase inhibitors, use of dopamine agonists, monoamine oxidase inhibitors, catechol-O-methyl transferase inhibitors and the development of nonoral delivery methods, in particular in the treatment of motor complications in later PD. There are some shortcomings of dopamine-based therapies including a limited benefit on the non-motor manifestations of Parkinson’s disease. We conclude by looking at the themes for future developments to further enhance dopamine delivery methods.
Collapse
Affiliation(s)
- Naveed M Malek
- Institute of Neurological Sciences, Southern General Hospital, Glasgow, G51 4TF, UK
| | - Donald G Grosset
- Institute of Neurological Sciences, Southern General Hospital, Glasgow, G51 4TF, UK
| |
Collapse
|